Balance Sheet DSM-Firmenich

Stocks

DSFIR

CH1216478797

Consumer Goods Conglomerates

Real-time Estimate Cboe Europe Other stock markets 11:20:00 2026-07-21 EDT			5-day change	1st Jan Change
77.78 ^CHF	-9.35%		+2.36%	+24.78%

07-20	European chemical earnings to test demand recovery after conflict-led pricing boost	RE
07-08	DSM-Firmenich slips despite share buybacks and Jefferies' positive view

be60d85c9385a546250cd531203a.2ygQfYzn6LiY54ysKuXTl3jaHw7wEHum-3qQ_wJzNOs.4kFTK8eVnO3fiNnqeKip5Em5UUixUTqVzgz0uEQAV5jufUAbu9Gp8auu1Q

Published financial data: DSM-FIRMENICH

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.2B	8.39B	10.63B	12.8B	9.03B
Total Revenues	9.2B	8.39B	10.63B	12.8B	9.03B
Cost of Goods Sold, Total	6.04B	5.7B	8.02B	8.55B	5.5B
Gross Profit	3.16B	2.69B	2.61B	4.24B	3.53B
Selling General & Admin Expenses, Total	1.79B	1.77B	2.54B	2.85B	2.21B
R&D Expenses	323M	295M	652M	888M	713M
Other Operating Expenses	29M	-29M	-16M	0	-21M
Other Operating Expenses, Total	2.14B	2.04B	3.17B	3.74B	2.9B
Operating Income	1.02B	652M	-560M	509M	629M
Interest Expense, Total	-92M	-104M	-138M	-162M	-154M
Interest And Investment Income	3M	22M	95M	70M	60M
Net Interest Expenses	-89M	-82M	-43M	-92M	-94M
Income (Loss) On Equity Invest.	16M	12M	-6M	-5M	-102M
Currency Exchange Gains (Loss)	-7M	-20M	-86M	-41M	-51M
Other Non Operating Income (Expenses)	-15M	-1M	-26M	1M	4M
EBT, Excl. Unusual Items	928M	561M	-721M	372M	386M
Merger & Related Restructuring Charges	-25M	-3M	-59M	-39M	-2M
Gain (Loss) On Sale Of Investments	326M	-7M	-1M	5M	-6M
Gain (Loss) On Sale Of Assets	13M	31M	17M	47M	43M
Insurance Settlements	11M	12M	53M	21M	39M
Legal Settlements	2M	-	-	-	-
Other Unusual Items	2M	5M	57M	21M	-
EBT, Incl. Unusual Items	1.26B	599M	-654M	427M	460M
Income Tax Expense	168M	124M	-18M	147M	118M
Earnings From Continuing Operations	1.09B	475M	-636M	280M	342M
Earnings Of Discontinued Operations	591M	1.24B	2.79B	-	-1.38B
Net Income to Company	1.68B	1.72B	2.15B	280M	-1.04B
Minority Interest	-4M	-15M	-16M	-30M	-42M
Net Income - (IS)	1.68B	1.7B	2.14B	250M	-1.08B
Preferred Dividend and Other Adjustments	6M	6M	6M	-	26M
Net Income to Common Incl Extra Items	1.67B	1.69B	2.13B	250M	-1.11B
Net Income to Common Excl. Extra Items	1.08B	454M	-658M	250M	274M
Per Share Items
Net EPS - Basic	9.67	9.8	9.14	0.94	-4.27
Basic EPS - Continuing Operations	6.25	2.63	-2.82	0.94	1.06
Basic Weighted Average Shares Outstanding	173M	173M	233M	265M	259M
Net EPS - Diluted	9.63	9.77	9.14	0.94	-4.27
Diluted EPS - Continuing Operations	6.22	2.61	-2.82	0.94	1.05
Diluted Weighted Average Shares Outstanding	173M	173M	233M	265M	259M
Normalized Basic EPS	3.34	1.94	-2	0.77	0.77
Normalized Diluted EPS	3.32	1.94	-2	0.77	0.77
Dividend Per Share	2.5	2.53	2.5	2.5	2.5
Payout Ratio	15.87	20.29	7.35	264	-60.96
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.62B	1.23B	352M	1.6B	1.44B
EBITA	1.24B	892M	-83M	1.12B	1.17B
EBIT	1.02B	652M	-560M	509M	629M
Effective Tax Rate - (Ratio)	13.37	20.7	2.75	34.43	25.65
Total Current Taxes	122M	107M	188M	324M	223M
Total Deferred Taxes	46M	17M	-206M	-177M	-105M
Normalized Net Income	576M	336M	-467M	202M	199M
Interest Capitalized	4M	3M	4M	6M	9M
Interest on Long-Term Debt	5M	6M	8M	15M	17M
Non-Cash Pension Expense	-7M	1M	7M	9M	11M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.27B	1.24B	1.51B	1.8B	1.28B
General and Administrative Expenses	517M	534M	1.02B	1.04B	925M
Research And Development Expense From Footnotes	334M	295M	652M	888M	713M
Stock-Based Comp., Other (Total)	22M	35M	29M	35M	35M
Total Stock-Based Compensation	22M	35M	29M	35M	35M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.56B	2.76B	2.46B	2.67B	1.78B
Short Term Investments	489M	125M	107M	50M	121M
Total Cash And Short Term Investments	2.05B	2.88B	2.56B	2.72B	1.9B
Accounts Receivable, Total	1.6B	1.51B	2.55B	2.59B	1.84B
Other Receivables	88M	78M	220M	145M	226M
Notes Receivable	-	24M	69M	23M	16M
Total Receivables	1.69B	1.61B	2.84B	2.76B	2.08B
Inventory	2.3B	2.34B	3.39B	3.29B	2.12B
Other Current Assets, Total	91M	1.3B	49M	35M	2.79B
Total Current Assets	6.13B	8.13B	8.84B	8.8B	8.89B
Gross Property Plant And Equipment	8.69B	7.44B	9.97B	10.18B	6.43B
Accumulated Depreciation	-4.73B	-3.87B	-4.42B	-4.45B	-2.26B
Net Property Plant And Equipment	3.96B	3.58B	5.55B	5.72B	4.17B
Long-term Investments	259M	196M	721M	568M	389M
Goodwill	2.95B	2.98B	11.29B	11.25B	9.45B
Other Intangibles, Total	2.36B	2.16B	7.44B	6.83B	5.94B
Loans Receivable Long-Term	1M	2M	11M	54M	78M
Deferred Tax Assets Long-Term	203M	95M	228M	299M	227M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	154M	259M	179M	224M	200M
Total Assets	16.01B	17.4B	34.27B	33.75B	29.34B
Liabilities
Accounts Payable, Total	1.56B	1.41B	2.06B	2.27B	1.48B
Accrued Expenses, Total	414M	345M	584M	643M	377M
Short-term Borrowings	44M	30M	31M	173M	43M
Current Portion of Long-Term Debt	13M	14M	604M	573M	1.54B
Current Portion of Leases	48M	44M	84M	90M	77M
Current Income Taxes Payable	77M	64M	177M	223M	303M
Unearned Revenue Current, Total	10M	4M	8M	5M	6M
Other Current Liabilities	264M	668M	968M	382M	1.77B
Total Current Liabilities	2.43B	2.58B	4.52B	4.36B	5.59B
Long-Term Debt	2.84B	2.84B	3.78B	4.01B	3.23B
Long-Term Leases	147M	135M	331M	434M	386M
Unearned Revenue Non Current	62M	55M	70M	63M	21M
Pension & Other Post Retirement Benefits	358M	266M	520M	487M	193M
Deferred Tax Liability Non Current	485M	476M	1.75B	1.56B	1.35B
Other Non Current Liabilities	291M	203M	226M	140M	147M
Total Liabilities	6.62B	6.56B	11.2B	11.05B	10.92B
Common Stock, Total	328M	328M	3M	3M	3M
Additional Paid In Capital	471M	471M	11.73B	11.31B	10.93B
Retained Earnings	8.54B	9.78B	10.74B	10.63B	8.41B
Treasury Stock	-177M	-196M	-44M	-147M	-1.21B
Comprehensive Income and Other	156M	363M	474M	710M	109M
Total Common Equity	9.32B	10.74B	22.91B	22.51B	18.24B
Minority Interest	79M	102M	162M	186M	179M
Total Equity	9.4B	10.84B	23.07B	22.7B	18.42B
Total Liabilities And Equity	16.01B	17.4B	34.27B	33.75B	29.34B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	173M	173M	265M	264M	252M
ECS Total Common Shares Outstanding	173M	173M	265M	264M	252M
Book Value / Share	53.87	62.07	86.35	85.18	72.53
Tangible Book Value	4.01B	5.6B	4.17B	4.43B	2.86B
Tangible Book Value Per Share	23.17	32.33	15.72	16.77	11.37
Total Debt	3.09B	3.07B	4.83B	5.28B	5.28B
Net Debt	1.04B	186M	2.27B	2.56B	3.37B
Debt Equivalent of Unfunded Proj. Benefit Obligation	248M	104M	309M	265M	41M
Minority Interest, Total (Incl. Fin. Div)	79M	102M	162M	186M	179M
Equity Method Investments, Total	64M	61M	130M	342M	199M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	621M	596M	1.02B	926M	624M
Inventories - Work In Process, Total	1.76B	1.81B	2.45B	2.48B	1.59B
Land - (BS)	2.11B	1.93B	2.96B	2.88B	1.96B
Machinery, Total	5.71B	4.62B	5.64B	5.65B	2.96B
Full Time Employees	21.36K	19.26K	28.68K	26.3K	26.87K
Part Time Employees	-	1.42K	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	23M	12M	15M	20M	14M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.68B	1.72B	2.15B	250M	-1.08B
Depreciation & Amortization - CF	425M	392M	510M	577M	354M
Amortization of Goodwill and Intangible Assets - (CF)	221M	240M	477M	609M	545M
Depreciation & Amortization, Total	646M	632M	987M	1.19B	899M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-649M	-1.02B	-2.84B	-47M	-114M
Asset Writedown & Restructuring Costs	35M	20M	320M	244M	47M
(Income) Loss On Equity Investments - (CF)	-342M	-5M	7M	-	107M
Stock-Based Compensation (CF)	22M	34M	23M	31M	38M
Net Cash From Discontinued Operations	-	72M	38M	-	589M
Other Operating Activities, Total	179M	18M	422M	-84M	1.17B
Change In Accounts Receivable	-194M	-133M	49M	-18M	-16M
Change In Inventories	-323M	-442M	89M	-38M	-89M
Change In Accounts Payable	334M	116M	126M	97M	5M
Change in Other Net Operating Assets	39M	-38M	-104M	157M	-110M
Cash from Operations	1.43B	965M	1.26B	1.78B	1.44B
Capital Expenditure	-433M	-506M	-555M	-645M	-628M
Sale of Property, Plant, and Equipment	27M	17M	16M	19M	64M
Cash Acquisitions	-704M	-74M	-3.69B	-5M	-19M
Divestitures	1.79B	1.37B	3.53B	42M	1.27B
Sale (Purchase) of Intangible assets	-144M	-145M	-137M	-119M	-136M
Investment in Marketable and Equity Securities, Total	-365M	360M	40M	432M	-62M
Net (Increase) Decrease in Loans Originated / Sold - Investing	19M	-152M	-2M	-23M	-21M
Other Investing Activities, Total	17M	10M	70M	47M	37M
Cash from Investing	208M	876M	-726M	-252M	505M
Short Term Debt Issued, Total	12M	-	-	38M	24M
Long-Term Debt Issued, Total	37M	51M	15M	833M	740M
Total Debt Issued	49M	51M	15M	871M	764M
Short Term Debt Repaid, Total	-	-21M	-7M	-	-
Long-Term Debt Repaid, Total	-567M	-86M	-622M	-733M	-669M
Total Debt Repaid	-567M	-107M	-629M	-733M	-669M
Issuance of Common Stock	34M	25M	757M	21M	5M
Repurchase of Common Stock	-165M	-210M	-256M	-706M	-1.18B
Common Dividends Paid	-	-	-151M	-660M	-659M
Preferred Dividends Paid	-	-	-6M	-	-
Common & Preferred Stock Dividends Paid	-266M	-345M	-	-	-
Common & Preferred Stock Dividends Paid	-266M	-345M	-157M	-660M	-659M
Special Dividend Paid	-	-	-425M	-	-
Other Financing Activities, Total	-69M	-59M	-125M	-127M	-1.01B
Cash from Financing	-984M	-645M	-820M	-1.33B	-2.75B
Foreign Exchange Rate Adjustments	39M	-2M	-18M	19M	-72M
Net Change in Cash	690M	1.19B	-299M	211M	-874M
Supplemental Items
Cash Interest Paid	65M	52M	61M	67M	64M
Cash Income Tax Paid (Refund)	133M	131M	179M	275M	320M
Levered Free Cash Flow	1.29B	-644M	185M	597M	-32.12M
Unlevered Free Cash Flow	1.34B	-578M	271M	698M	64.12M
Change In Net Working Capital	-614M	1B	-297M	77M	499M
Net Debt Issued / Repaid	-518M	-56M	-614M	138M	95M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.21	2.44	-1.35	0.94	1.25
Return on Total Capital	5.43	3.09	-1.67	1.14	1.52
Return On Equity %	12.9	4.69	-3.75	1.22	1.66
Return on Common Equity	12.91	4.53	-3.91	1.1	1.34
Margin Analysis
Gross Profit Margin %	34.38	32.06	24.57	33.17	39.07
SG&A Margin	19.44	21.12	23.85	22.25	24.45
EBITDA Margin %	17.58	14.71	3.31	12.49	15.92
EBITA Margin %	13.52	10.63	-0.78	8.74	13
EBIT Margin %	11.11	7.77	-5.27	3.98	6.96
Income From Continuing Operations Margin %	11.83	5.66	-5.98	2.19	3.79
Net Income Margin %	18.21	20.26	20.11	1.95	-11.97
Net Avail. For Common Margin %	11.72	5.41	-6.19	1.95	3.03
Normalized Net Income Margin	6.26	4	-4.39	1.58	2.21
Levered Free Cash Flow Margin	13.98	-7.67	1.74	4.66	-0.36
Unlevered Free Cash Flow Margin	14.61	-6.9	2.55	5.45	0.71
Asset Turnover
Asset Turnover	0.61	0.5	0.41	0.38	0.29
Fixed Assets Turnover	2.38	2.23	2.33	2.27	1.83
Receivables Turnover (Average Receivables)	6.15	5.39	5.23	4.98	4.08
Inventory Turnover (Average Inventory)	2.89	2.46	2.8	2.56	2.03
Short Term Liquidity
Current Ratio	2.52	3.15	1.96	2.02	1.59
Quick Ratio	1.54	1.73	1.18	1.25	0.71
Operating Cash Flow to Current Liabilities	0.59	0.37	0.28	0.41	0.26
Days Sales Outstanding (Average Receivables)	59.37	67.69	69.74	73.52	89.49
Days Outstanding Inventory (Average Inventory)	126.18	148.43	130.43	142.91	179.42
Average Days Payable Outstanding	78.22	94.46	69.92	96.05	157.7
Cash Conversion Cycle (Average Days)	107.32	121.67	130.25	120.38	111.2
Long Term Solvency
Total Debt/Equity	32.93	28.27	20.95	23.26	28.64
Total Debt / Total Capital	24.77	22.04	17.32	18.87	22.27
LT Debt/Equity	31.81	27.46	17.83	19.58	19.63
Long-Term Debt / Total Capital	23.93	21.41	14.74	15.88	15.26
Total Liabilities / Total Assets	41.32	37.68	32.68	32.74	37.22
EBIT / Interest Expense	11.12	6.27	-4.06	3.14	4.08
EBITDA / Interest Expense	18.14	12.35	3.09	10.46	9.92
(EBITDA - Capex) / Interest Expense	13.43	7.48	-0.93	6.48	5.84
Total Debt / EBITDA	1.85	2.39	11.32	3.12	3.45
Net Debt / EBITDA	0.63	0.14	5.32	1.51	2.21
Total Debt / (EBITDA - Capex)	2.5	3.94	-37.76	5.03	5.86
Net Debt / (EBITDA - Capex)	0.84	0.24	-17.73	2.44	3.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.55	15.42	26.66	20.44	-0.22
Gross Profit, 1 Yr. Growth %	13.98	2.99	-2.94	62.58	-0.65
EBITDA, 1 Yr. Growth %	33.83	-5.44	-71.47	363.48	4.51
EBITA, 1 Yr. Growth %	43.82	-4.19	-109.3	-1.45K	8.4
EBIT, 1 Yr. Growth %	52.23	-8.17	-185.89	-190.89	19.35
Earnings From Cont. Operations, 1 Yr. Growth %	138.29	-42.77	-233.89	-144.03	-4.74
Net Income, 1 Yr. Growth %	231.23	1.43	25.71	-88.3	-532.4
Normalized Net Income, 1 Yr. Growth %	75.94	-12.48	-239.03	-143.4	-6.51
Diluted EPS Before Extra, 1 Yr. Growth %	139.82	-44.69	-207.91	-133.31	-7.36
Accounts Receivable, 1 Yr. Growth %	15.24	-5.99	69.3	1.41	-28.89
Inventory, 1 Yr. Growth %	22.25	1.83	44.93	-2.95	-35.53
Net Property, Plant and Equip., 1 Yr. Growth %	4.82	-9.79	55.17	3.17	-27.09
Total Assets, 1 Yr. Growth %	11.62	8.63	96.92	-1.53	-13.04
Tangible Book Value, 1 Yr. Growth %	35.45	39.59	-25.48	6.31	-35.48
Common Equity, 1 Yr. Growth %	25.94	15.29	113.24	-1.73	-18.96
Cash From Operations, 1 Yr. Growth %	-4.48	-32.38	31.09	40.55	-18.73
Capital Expenditures, 1 Yr. Growth %	-5.46	16.86	9.68	16.22	-2.64
Levered Free Cash Flow, 1 Yr. Growth %	-622.59	-159.02	-127.76	235.79	-109.12
Unlevered Free Cash Flow, 1 Yr. Growth %	-807.57	-150.4	-145.13	164.44	-85.76
Dividend Per Share, 1 Yr. Growth %	4.17	1.2	-1.19	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.27	1.74	20.91	23.51	-7.8
Gross Profit, 2 Yr. CAGR %	6.99	-1.56	-0.02	25.62	16.27
EBITDA, 2 Yr. CAGR %	12.21	1.03	-48.06	13.83	104.16
EBITA, 2 Yr. CAGR %	13.01	1.55	-70.14	11.95	276.09
EBIT, 2 Yr. CAGR %	12.59	-1.5	-11.19	-11.64	5.98
Earnings From Cont. Operations, 2 Yr. CAGR %	25.72	1.95	-12.46	-23.22	-26.67
Net Income, 2 Yr. CAGR %	48.7	83.29	12.92	-61.65	-28.88
Normalized Net Income, 2 Yr. CAGR %	15.2	1.25	10.31	-22.32	-34.65
Diluted EPS Before Extra, 2 Yr. CAGR %	27.69	0.4	-22.75	-40.04	-38.89
Accounts Receivable, 2 Yr. CAGR %	0.34	4.12	26.16	31.03	-15.08
Inventory, 2 Yr. CAGR %	6.66	11.57	21.48	18.6	-20.9
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.03	-2.67	18.32	26.53	-13.27
Total Assets, 2 Yr. CAGR %	9.14	10.14	46.26	39.25	-7.46
Tangible Book Value, 2 Yr. CAGR %	-2.5	37.52	1.99	-11	-17.18
Common Equity, 2 Yr. CAGR %	9.79	20.5	56.8	44.76	-10.76
Cash From Operations, 2 Yr. CAGR %	1.5	-19.63	-5.85	35.74	6.88
Capital Expenditures, 2 Yr. CAGR %	-8.75	5.11	13.21	12.9	6.37
Levered Free Cash Flow, 2 Yr. CAGR %	181.52	61.65	-58.84	-5.3	-57.49
Unlevered Free Cash Flow, 2 Yr. CAGR %	145.88	74.49	-51.41	7.82	-50.72
Dividend Per Share, 2 Yr. CAGR %	2.06	2.67	0	-0.59	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.23	1.61	9.45	20.75	2.5
Gross Profit, 3 Yr. CAGR %	-2.42	-0.9	-2.02	17.57	9.48
EBITDA, 3 Yr. CAGR %	-0.99	-1.34	-33.72	7.01	5.23
EBITA, 3 Yr. CAGR %	-2.62	-2.89	-54.22	6.29	9.59
EBIT, 3 Yr. CAGR %	-5.42	-6.86	-5.9	-10.5	-1.19
Earnings From Cont. Operations, 3 Yr. CAGR %	0.31	-11.66	11.65	-30.39	-10.37
Net Income, 3 Yr. CAGR %	15.88	30.9	61.64	-46.97	-14.01
Normalized Net Income, 3 Yr. CAGR %	-6.15	-8.21	12.54	-19.17	-15.95
Diluted EPS Before Extra, 3 Yr. CAGR %	0.88	-11.84	2.84	-41.64	-26.13
Accounts Receivable, 3 Yr. CAGR %	0.59	-1.79	22.44	17.3	6.88
Inventory, 3 Yr. CAGR %	4.85	5.03	21.74	12.72	-3.21
Net Property, Plant and Equip., 3 Yr. CAGR %	4.07	-3.99	13.7	13.04	5.29
Total Assets, 3 Yr. CAGR %	5.49	8.99	33.68	28.19	19.02
Tangible Book Value, 3 Yr. CAGR %	-5.12	9.9	12.12	3.41	-20.05
Common Equity, 3 Yr. CAGR %	6.19	11.59	45.75	34.18	19.31
Cash From Operations, 3 Yr. CAGR %	0.86	-11.35	-5.4	7.61	14.41
Capital Expenditures, 3 Yr. CAGR %	-8.49	-0.91	6.61	14.21	7.47
Levered Free Cash Flow, 3 Yr. CAGR %	50.57	58.25	-9.13	-18.19	-63.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	45.37	37.53	12.57	-15.27	-52.56
Dividend Per Share, 3 Yr. CAGR %	2.82	1.77	1.37	0	-0.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.05	-0.57	2.78	9.86	2.19
Gross Profit, 5 Yr. CAGR %	3.55	-1.71	-5.17	8.96	4.92
EBITDA, 5 Yr. CAGR %	8.42	-0.32	-26.73	4.47	3.53
EBITA, 5 Yr. CAGR %	10.27	-0.96	-42.73	2.8	6.3
EBIT, 5 Yr. CAGR %	10.36	-3.94	-14.27	-8.81	-1.31
Earnings From Cont. Operations, 5 Yr. CAGR %	10.64	-23.23	-10.03	-16.48	-5.63
Net Income, 5 Yr. CAGR %	21.97	-0.79	14.69	-19.9	16.4
Normalized Net Income, 5 Yr. CAGR %	15.41	-1.89	-7.7	-14.14	-9.45
Diluted EPS Before Extra, 5 Yr. CAGR %	11.13	-23.59	-14.18	-24.44	-16.49
Accounts Receivable, 5 Yr. CAGR %	1.28	-0.44	10.14	10.21	5.77
Inventory, 5 Yr. CAGR %	5	4.83	11.21	10.26	2.45
Net Property, Plant and Equip., 5 Yr. CAGR %	3.54	1.54	9.59	7.22	2.03
Total Assets, 5 Yr. CAGR %	4.32	6.33	20.23	20.21	15.39
Tangible Book Value, 5 Yr. CAGR %	6.8	7.47	-2.33	1.01	-0.68
Common Equity, 5 Yr. CAGR %	8.94	9.06	24.1	23.83	19.78
Cash From Operations, 5 Yr. CAGR %	6.99	-0.63	-1.88	5.12	-0.66
Capital Expenditures, 5 Yr. CAGR %	0.95	2.42	-0.36	4.4	6.52
Levered Free Cash Flow, 5 Yr. CAGR %	29.9	32.62	-13.29	29.74	-33.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.1	19.93	-9.14	25.71	-19.53
Dividend Per Share, 5 Yr. CAGR %	7.39	6.46	1.68	0.82	0.82